Over 1.84 billion Covid vaccine doses administered in India: Govt

Over 1.59 crore (1,59,51,459) vaccine doses have so far been administered to beneficiaries in the age group of 12-14 years

vaccine
The country launched vaccination for all people aged above 45 years from April 1 last year
Press Trust of India New Delhi
2 min read Last Updated : Mar 30 2022 | 9:17 PM IST

The cumulative number of COVID-19 vaccine doses administered in the country crossed 184 crore on Wednesday, according to the Union health ministry.

More than 19 lakh (19,24,770) vaccine doses were administered till 7 pm on Wednesday, the ministry said, adding that the daily vaccination tally is expected to go up with the compilation of the final reports by late night.

Over 1.59 crore (1,59,51,459) vaccine doses have so far been administered to beneficiaries in the age group of 12-14 years, it said.

More than 2.3 crore (2,30,03,879) precaution doses of the vaccines have been given to healthare workers (HCWs), frontline workers (FLWs) and those aged 60 years and above.

The countrywide vaccination drive against the viral disease was rolled out on January 16 last year, with the HCWs getting inoculated in the first phase. The vaccination of the FLWs started from February 2 last year.

The next phase of Covid vaccination commenced on March 1 last year for people over 60 years of age and those aged 45 and above with specified co-morbid conditions.

The country launched vaccination for all people aged above 45 years from April 1 last year.

The Centre then decided to expand the vaccination drive by allowing everyone above 18 years of age to be inoculated against the disease from May 1 last year.

The next phase of Covid vaccination commenced from January 3 this year for adolescents in the age group of 15-18 years.

The country began administering precaution doses of the vaccines to the HCWs, the FLWs and those aged 60 years and above with comorbidities from January 10 this year.

The inoculation of children aged 12-14 started from March 16.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusDelta variant of coronavirusCoronavirus VaccineIndia vaccinationVaccinationCoronavirus Tests

First Published: Mar 30 2022 | 9:17 PM IST

Next Story